Adaltis Inc.

Adaltis Inc.

May 05, 2008 15:20 ET

Notice of Adaltis Annual Shareholders Meeting and 2008 First Quarter Results

MONTREAL, QUEBEC--(Marketwire - May 5, 2008) - Adaltis Inc. (TSX:ADS), an international in vitro diagnostic company, today announced that the Company will hold its annual meeting of shareholders on Thursday, May 8, 2008 at 11:00 a.m. ET. The meeting will be held at the Palais des congres de Montreal, room 512DH, located at 159 Saint-Antoine St. West, Montreal, Quebec.

In addition, the Company's 2008 first quarter summary results will be released prior to the beginning of the annual shareholders meeting on May 8, 2008.

About Adaltis

Adaltis is an international in vitro diagnostic company that develops, manufactures and markets diagnostic systems. It aims to leverage its experience in Europe to become a leading provider of in vitro diagnostic products in emerging markets, with a particular focus on China.

With the assistance of its two strategic shareholders, CITIC Pacific Limited (a large Hong Kong-based conglomerate) and Picchio Pharma Inc. (a joint venture healthcare investment firm owned by FMRC Family Trust (a trust of which Dr. Francesco Bellini is a beneficiary), and Power Technology Investment Corporation, a subsidiary of Power Corporation of Canada), Adaltis has completed building its manufacturing facility in Shanghai. Now operational, the production facility manufactures high-quality products in a low-cost GMP environment, in order to service existing markets in Europe, while providing a platform to penetrate the high-growth Chinese in vitro diagnostic market.

Adaltis is headquartered in Montreal, with offices in China, Hong Kong, Italy, Germany and Mexico.

Contact Information